# Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE)

> **NCT02196909** · NA · COMPLETED · sponsor: **Institut de Myologie, France** · enrollment: 20 (actual)

## Conditions studied

- HIBM

## Interventions

- **OTHER:** motor function and strength assessment
- **OTHER:** NMR assessment
- **OTHER:** 24h urine and serum collection

## Key facts

- **NCT ID:** NCT02196909
- **Lead sponsor:** Institut de Myologie, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02196909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02196909, "Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02196909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*